TXG
10x Genomics·NASDAQ
--
--(--)
--
--(--)
TXG fundamentals
10x Genomics (TXG) Revenue Breakdown: Q4 2025 Business & Regional Performance
10x Genomics (TXG) reported total revenue of 166.03M USD in Q4 2025, with its core business segment Instruments contributing 9.32%. Regionally, North America remained the largest market, accounting for 49.49% of total revenue. Explore 10x Genomics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
10x Genomics (TXG) reported total revenue of 166.03M USD in Q4 2025, with its core business segment Instruments contributing 9.32%. Regionally, North America remained the largest market, accounting for 49.49% of total revenue. Explore 10x Genomics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for 10x Genomics year over year?What does 10x Genomics do and what are its main business segments?What is 10x Genomics's latest dividend and current dividend yield?What were the key takeaways from 10x Genomics’s earnings call?What is 10x Genomics's gross profit margin?What guidance did 10x Genomics's management provide for the next earnings period?What is the market's earnings forecast for 10x Genomics next quarter?What factors drove the changes in 10x Genomics's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
